Dr Andrew Gallimore, who has a PhD was in biological chemistry, said he encountered these beings firsthand after being ...

Busting stigma is no small task, especially when it involves convincing the public that a psychedelic drug might one day be ...

Cybin has made steady progress but faces major hurdles, with its stock swayed by sector sentiment. Read why CYBN stock is ...